Tumors with nonfunctional retinoblastoma protein are killed by reduced γ-tubulin levels

Journal of Biological Chemistry

Volumn 287, Issue 21, 2012, Pages 17241-17247

  Ehlén, Åsa ^a   Rosselló, Catalina A ^a   Von Stedingk, Kristoffer ^a   Höög, Greta ^a   Nilsson, Elise ^a   Pettersson, Helen M ^a   Jirström, Karin ^a   Alvarado Kristensson, Maria ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOTIC GENES; CASPASE-3; EXPRESSION LEVELS; GENE PROMOTER; GROWTH CONTROL; INVERSE CORRELATION; PROTEIN LEVEL; RETINOBLASTOMA PROTEIN; SIGNALING PATHWAYS; SIMULTANEOUS REDUCTION; TUMOR CELL LINES; UP-REGULATION;

CELL CULTURE; CELL DEATH; GENE EXPRESSION; TUMORS;

PROTEINS;

CASPASE 3; GAMMA TUBULIN; RETINOBLASTOMA 1 PROTEIN; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER CELL; CANCER CLASSIFICATION; CELL LEVEL; COLORECTAL CANCER; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INDUCTION; GENETIC ASSOCIATION; GENETIC CORRELATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG SMALL CELL CANCER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; UPREGULATION;

ANIMALS; APOPTOSIS; CASPASE 3; CELL LINE, TUMOR; E2F1 TRANSCRIPTION FACTOR; HUMANS; MICE; NEOPLASMS; NIH 3T3 CELLS; RETINOBLASTOMA PROTEIN; SIGNAL TRANSDUCTION; TUBULIN;

EID: 84861205944     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.357038     Document Type: Article

References (24)

1. Hanahan, D., and Weinberg, R. A. (2000) The hallmarks of cancer. Cell 100, 57-70 (Pubitemid 30046295)
2. Höög, G., Zarrizi, R., von Stedingk, K., Jonsson, K., and Alvarado-Kristensson, M. (2011) Nuclear localization of γ-tubulin affects E2F transcriptional activity and S-phase progression. FASEB J. 25, 3815-3827
3. Nahle, Z., Polakoff, J., Davuluri, R. V., McCurrach, M. E., Jacobson, M. D., Narita, M., Zhang, M. Q., Lazebnik, Y., Bar-Sagi, D., and Lowe, S. W. (2002) Direct coupling of the cell cycle and cell death machinery by E2F. Nat. Cell Biol. 4, 859-864 (Pubitemid 35331360)
4. Sellers, W. R., Novitch, B. G., Miyake, S., Heith, A., Otterson, G. A., Kaye, F. J., Lassar, A. B., and Kaelin, W. G., Jr. (1998) Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth. Genes Dev. 12, 95-106 (Pubitemid 28083661)
5. Alvarado-Kristensson, M., Rodríguez, M. J., Silió, V., Valpuesta, J. M., and Carrera, A. C. (2009) SADB phosphorylation of γ-tubulin regulates centrosome duplication. Nat. Cell Biol. 11, 1081-1092
6. Munksgaard Persson, M., Johansson, M. E., Monsef, N., Planck, M., Beckman, S., Seckl, M. J., Rönnstrand, L., Påhlman, S., and Pettersson, H. M. (2012) HIF-2α expression is suppressed in SCLC cells, which survive in moderate and severe hypoxia when HIF-1α is repressed. Am. J. Pathol. 180, 494-504
7. Ehlén, A., Brennan, D. J., Nodin, B., O'Connor, D. P., Eberhard, J., Alvarado- Kristensson, M., Jeffrey, I. B., Manjer, J., Brändstedt, J., Uhlén, M., Pontén, F., and Jirström, K. (2010) Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer. J. Transl. Med. 8, 78-89
8. Alvarado-Kristensson, M., Melander, F., Leandersson, K., Rönnstrand, L., Wernstedt, C., and Andersson, T. (2004) p38-MAPK signals survival by phosphorylation of caspase-8 and caspase-3 in human neutrophils. J. Exp. Med. 199, 449-458 (Pubitemid 38233829)
9. De Preter, K., Speleman, F., Combaret, V., Lunec, J., Laureys, G., Eussen, B. H., Francotte, N., Board, J., Pearson, A. D., De Paepe, A., Van Roy, N., and Vandesompele, J. (2002) Quantification of MYCN, DDX1, and NAG gene copy number in neuroblastoma using a real-time quantitative PCR assay. Mod. Pathol. 15, 159-166 (Pubitemid 34171326)
10. Stransky, N., Vallot, C., Reyal, F., Bernard-Pierrot, I., de Medina, S. G., Segraves, R., de Rycke, Y., Elvin, P., Cassidy, A., Spraggon, C., Graham, A., Southgate, J., Asselain, B., Allory, Y., Abbou, C. C., Albertson, D. G., Thiery, J. P., Chopin, D. K., Pinkel, D., and Radvanyi, F. (2006) Regional copy number-independent deregulation of transcription in cancer. Nat. Genet. 38, 1386-1396 (Pubitemid 44837560)
11. Mizuarai, S., Machida, T., Kobayashi, T., Komatani, H., Itadani, H., and Kotani, H. (2011) Expression ratio of CCND1 to CDKN2A mRNA predicts RB1 status of cultured cancer cell lines and clinical tumor samples. Mol. Cancer 10, 31-41
12. Elkabets, M., Gifford, A. M., Scheel, C., Nilsson, B., Reinhardt, F., Bray, M. A., Carpenter, A. E., Jirström, K., Magnusson, K., Ebert, B. L., Pontén, F., Weinberg, R. A., and McAllister, S. S. (2011) Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice. J. Clin. Invest. 121, 784-799
13. Gaber, A., Johansson, M., Stenman, U. H., Hotakainen, K., Pontén, F., Glimelius, B., Bjartell, A., Jirström, K., and Birgisson, H. (2009) High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer. Br. J. Cancer 100, 1540-1548
14. Svensson, K. J., Christianson, H. C., Kucharzewska, P., Fagerström, V., Lundstedt, L., Borgquist, S., Jirström, K., and Belting, M. (2011) Chondroitin sulfate expression predicts poor outcome in breast cancer. Int. J. Oncol. 39, 1421-1428
15. Kononen, J., Bubendorf, L., Kallioniemi, A., Bärlund, M., Schraml, P., Leighton, S., Torhorst, J., Mihatsch, M. J., Sauter, G., and Kallioniemi, O. P. (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat. Med. 4, 844-847 (Pubitemid 28331029)
16. Chen, H. Z., Tsai, S. Y., and Leone, G. (2009) Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nat. Rev. Cancer 9, 785-797
17. Harbour, J. W., and Dean, D. C. (2000) The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev. 14, 2393-2409
18. Lee, E. Y., Bookstein, R., Young, L. J., Lin, C. J., Rosenfeld, M. G., and Lee, W. H. (1988) Molecular mechanism of retinoblastoma gene inactivation in retinoblastoma cell line Y79. Proc. Natl. Acad. Sci. U.S.A. 85, 6017-6021
19. 2+ and resistance modulation by verapamil in absence of P-glycoprotein overexpression. Br. J. Cancer 64, 1011-1018
20. Adams, P. D. (2001) Regulation of the retinoblastoma tumor suppressor protein by cyclin/cdks. Biochim. Biophys. Acta 1471, M123-133
21. Qin, X. Q., Livingston, D. M., Kaelin, W. G., Jr., and Adams, P. D. (1994) Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. U.S.A. 91, 10918 -10922
22. Biswas, A. K., and Johnson, D. G. (2012) Transcriptional and nontranscriptional functions of E2F1 in response toDNAdamage. Cancer Res. 72, 13-17
23. Molenaar, J. J., Ebus, M. E., Koster, J., van Sluis, P., van Noesel, C. J., Versteeg, R., and Caron, H. N. (2008) Cyclin D1 and CDK4 activity contribute to the undifferentiated phenotype in neuroblastoma. Cancer Res. 68, 2599-2609 (Pubitemid 351556258)
24. Zhang, J., Mullighan, C. G., Harvey, R. C., Wu, G., Chen, X., Edmonson, M., Buetow, K. H., Carroll, W. L., Chen, I. M., Devidas, M., Gerhard, D. S., Loh, M. L., Reaman, G. H., Relling, M. V., Camitta, B. M., Bowman, W. P., Smith, M. A., Willman, C. L., Downing, J. R., and Hunger, S. P. (2011) Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood 118, 3080-3087